Related Experiment Videos
Liposomes, a potential immunoadjuvant and carrier for a cryptococcal vaccine
M P Lambros1, F Schafer, R Blackstock
1College of Pharmacy and Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190, USA.
Journal of Pharmaceutical Sciences
|September 2, 1998
Summary
Liposomes carrying cryptococcal antigens (CneF-liposome) induced a cell-mediated immune response (CMI) in mice, enhancing the clearance of Cryptococcus neoformans infection. This immunization strategy shows promise for controlling cryptococcal infections.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccine Development
Background:
- Cell-mediated immunity (CMI) is crucial for controlling Cryptococcus neoformans infections.
- Delayed-type hypersensitivity (DTH) reactions and pathogen clearance are key indicators of CMI.
- Complete Freund's adjuvant (CFA) is a traditional adjuvant for inducing CMI.
Purpose of the Study:
- To evaluate the anticryptococcal DTH reactivity and pathogen clearance elicited by CneF encapsulated in liposomes (CneF-liposome).
- To compare the efficacy of CneF-liposome immunization with CneF-CFA immunization.
- To assess the potential of liposomes as carriers for cryptococcal antigens.
Main Methods:
- CBA/J mice were immunized with CneF-liposome, CneF-CFA, or control formulations.
- DTH responses were measured by footpad testing six days post-immunization.
- Cryptococcal clearance was assessed seven days after intravenous challenge by enumerating colony-forming units (CFU) in tissues.
Main Results:
- CneF-liposome induced a positive anticryptococcal DTH response and increased pathogen clearance compared to saline-liposome controls.
- While CneF-liposome showed less DTH response and protection than CneF-CFA, it demonstrated significant anticryptococcal effects.
- Liposome encapsulation of CneF antigen provided partial protection against C. neoformans infection.
Conclusions:
- Liposomes are effective carriers for cryptococcal antigens, eliciting a protective immune response.
- Liposome-based immunization can enhance the clearance of C. neoformans from infected tissues.
- Further development of liposomal vaccines may offer a viable strategy for managing cryptococcal infections.